The Journal of Infectious Diseases · 2009 · 64 citations · 12 references
Life SciencesGeneticsMolecular GeneticsMolecular VirologyPharmacogeneticsVirologyAcquired ResistanceAntiretroviral TherapyAntiviral Drug ResistanceAntiviral ResistanceViral GeneticsViral MutationAntiviral Resistance MutationsDrug Resistance MutationsMolecular Drug ResistanceMutation-driven ResistanceNucleoside Reverse Transcriptase InhibitorsResistance-associated MutationsResistance-associated Viral VariantsReverse Transcriptase Inhibitor Resistance
Recently, we described a novel nucleotide template-based mechanism that may be the basis for the facilitated acquisition of the K65R resistance mutation in subtype C versus subtype B human immunodeficiency virus type 1 (HIV-1). In this article, we evaluated the effects of subtype C-specific silent polymorphisms in cell culture drug-selection experiments using nucleoside and nucleotide reverse-transcriptase inhibitors. The K65R pathway was selected more frequently in a subtype B virus that contained subtype C nucleotide polymorphisms at both positions 64 and 65 than in a wild-type NL4-3 subtype B virus. This is the first demonstration of the significance of silent nucleotide polymorphisms in the development of drug resistance.
12
Mina C. Hosseinipour, Joep JG van Oosterhout, Ralf Weigel et al. · AIDS · 2009 · 285 citations · Full text